Aggregated News

Untitled Document

The 23andMe test and other similar direct-to-consumer (DTC) genetic tests are likely here to stay. Those in favour see them as a way of engaging the public with science and making it fun, but there are problematic aspects, too. The issue of interpretation of the results is perhaps of greatest concern.

In BioNews 788, Professor Joyce Harper highlights some of the issues that the general public need to be aware of should they undertake such testing.

Read more...